BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3090097)

  • 21. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
    Fluker MR; Marshall LA; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal responses to the new potent GnRH antagonist Cetrorelix.
    Klingmüller D; Schepke M; Enzweiler C; Bidlingmaier F
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):15-8. PubMed ID: 8447189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
    Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
    J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies.
    Mortola JF; Sathanandan M; Pavlou S; Dahl KD; Hsueh AJ; Rivier J; Vale W; Yen SS
    Fertil Steril; 1989 Jun; 51(6):957-63. PubMed ID: 2498133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.
    Behre HM; Klein B; Steinmeyer E; McGregor GP; Voigt K; Nieschlag E
    J Clin Endocrinol Metab; 1992 Aug; 75(2):393-8. PubMed ID: 1639941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
    Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
    J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.
    Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men.
    Behre HM; Kliesch S; Pühse G; Reissmann T; Nieschlag E
    J Clin Endocrinol Metab; 1997 May; 82(5):1403-8. PubMed ID: 9141524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of ovarian 3 beta-hydroxysteroid dehydrogenase activity by gonadotropin-releasing hormone and follicle-stimulating hormone in cultured rat granulosa cells.
    Jones PB; Hsueh AJ
    Endocrinology; 1982 May; 110(5):1663-71. PubMed ID: 6804208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men.
    Jockenhövel F; Bhasin S; Steiner BS; Rivier JE; Vale WW; Swerdloff RS
    J Clin Endocrinol Metab; 1988 May; 66(5):1065-70. PubMed ID: 3129447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development.
    Wang C; Zhong CQ; Leung A; Low LC
    J Clin Endocrinol Metab; 1990 Mar; 70(3):615-9. PubMed ID: 2106526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory response of the luteinizing-hormone (LH)-releasing hormone (LHRH)/LH pulse generator after administration of a potent LHRH antagonist in the ram.
    Lincoln GA; Fraser HM
    Endocrinology; 1987 Jun; 120(6):2245-50. PubMed ID: 3032581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone.
    Cetel NS; Rivier J; Vale W; Yen SS
    J Clin Endocrinol Metab; 1983 Jul; 57(1):62-5. PubMed ID: 6406535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism.
    Padmanabhan V; Kelch RP; Sonstein J; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1988 Oct; 67(4):793-800. PubMed ID: 3138278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosterone in vivo increases pituitary follicle-stimulating hormone (FSH)-beta messenger ribonucleic acid content and serum FSH bioactivity selectively in female rats.
    McAndrews JM; Ringstrom SJ; Dahl KD; Schwartz NB
    Endocrinology; 1994 Jan; 134(1):158-63. PubMed ID: 8275929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonist.
    Leal JA; Williams RF; Danforth DR; Gordon K; Hodgen GD
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1325-7. PubMed ID: 3142920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men.
    Tenover JS; Dahl KD; Hsueh AJ; Lim P; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1103-8. PubMed ID: 3106393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.